Artículos del autor

solaci

Antiplatelet

ESC 2019 | THEMIS-PCI: Unlike in the Main Study, Here Ticagrelor Is Indeed Effective

This is a sub-study of the THEMIS presented during the ESC 2019 scientific sessions in Paris, and...
solaci -
Antiplatelet

ESC 2019 | THEMIS: Ticagrelor in Diabetics with Stable Coronary Artery Disease

The use of ticagrelor in patients with stable coronary artery disease significantly reduces the rate of major...
solaci -
Antiplatelet

ESC 2019 | POPULAR AGE: Good Old Clopidogrel Still Valid

According to this study, presented during the ESC 2019 scientific sessions, non-ST acute coronary syndrome (NSTE-ACS) patients...
solaci -
Mitral valve

Can We Treat Severe Residual Mitral Regurgitation after MitraClip without Surgery?

Courtesy of Dr. Carlos Fava. Edge to edge with MitraClip was shown effective and safe, and its outcomes...
solaci -
Structural heart disease

Physiological and Clinical Changes After Tricuspid Repair

After the recent announcement by the US Food and Drug Administration (FDA) green-lighting transcatheter aortic valve replacement...
solaci -
Coronary disease

The Most Read Articles of July in solaci website

1-Though Systolic BP Seems More Important, Diastolic BP Should Not Be Disregarded Systolic hypertension is more often associated...
solaci -
Highlights

Panamá Sessions 2019 | Highlights

solaci -
Institutional News

All you Need to Know About the SOLACI Sessions 2019

After 12 years, SOLACI returns to Panamá to continue promoting the development of interventional cardiology in Latin...
solaci -